CL2009001721A1 - Uso de bendamustina para preparar un medicamento util para tratar el cancer. - Google Patents
Uso de bendamustina para preparar un medicamento util para tratar el cancer.Info
- Publication number
- CL2009001721A1 CL2009001721A1 CL2009001721A CL2009001721A CL2009001721A1 CL 2009001721 A1 CL2009001721 A1 CL 2009001721A1 CL 2009001721 A CL2009001721 A CL 2009001721A CL 2009001721 A CL2009001721 A CL 2009001721A CL 2009001721 A1 CL2009001721 A1 CL 2009001721A1
- Authority
- CL
- Chile
- Prior art keywords
- bendamustine
- prepare
- treat cancer
- useful medicine
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Uso de bendamustina para tratar el cáncer, donde el cáncer es resistente a la apoptosis, tal como linfoma no hodgkin y leucemia linfocítica crónica (divisional de la solicitud 2878-05).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62519304P | 2004-11-05 | 2004-11-05 | |
US66022605P | 2005-03-10 | 2005-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001721A1 true CL2009001721A1 (es) | 2010-02-19 |
Family
ID=36588320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001721A CL2009001721A1 (es) | 2004-11-05 | 2009-08-12 | Uso de bendamustina para preparar un medicamento util para tratar el cancer. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20060128777A1 (es) |
EP (1) | EP1814544A4 (es) |
JP (1) | JP2008519047A (es) |
CN (1) | CN101933923A (es) |
AR (1) | AR054094A1 (es) |
AU (1) | AU2005317047A1 (es) |
CA (1) | CA2585659A1 (es) |
CL (1) | CL2009001721A1 (es) |
MX (1) | MX2007005361A (es) |
NO (1) | NO20072654L (es) |
TW (1) | TW200621240A (es) |
WO (1) | WO2006065392A2 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ542445A (en) | 2003-04-07 | 2008-03-28 | Pharmacyclics Inc | Hydroxamates as therapeutic agents |
US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
US20090075967A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched ceftriaxone |
US20090082416A1 (en) * | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched bendamustine |
AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
US8962614B2 (en) * | 2008-04-17 | 2015-02-24 | The Johns Hopkins University | ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors |
MX2011002936A (es) * | 2008-09-25 | 2011-04-11 | Cephalon Inc | Formulaciones liquidas de bendamustina. |
UA107186C2 (xx) * | 2008-12-03 | 2014-12-10 | Тверді форми дозування бендамустину | |
UA102120C2 (ru) * | 2008-12-03 | 2013-06-10 | Астеллас Дойчленд Гмбх | Пероральная форма дозирования бендамустина |
CN102421451B (zh) * | 2009-02-25 | 2013-11-06 | 休普拉特克药品有限公司 | 苯达莫司汀环多糖组合物 |
US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
CN102413816A (zh) * | 2009-04-28 | 2012-04-11 | 赛福伦公司 | 苯达莫司汀的口服制剂 |
WO2010144675A1 (en) | 2009-06-10 | 2010-12-16 | Plus Chemicals Sa | Polymorphs of bendamustine hcl and processes for preparation thereof |
US8389558B2 (en) * | 2009-07-20 | 2013-03-05 | Supratek Pharma Inc. | Bendamustine amphiphilic anionic compositions |
PL3158991T3 (pl) * | 2010-01-28 | 2021-09-27 | Eagle Pharmaceuticals, Inc. | Preparaty bendamustyny |
JO3659B1 (ar) * | 2010-06-02 | 2020-08-27 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية |
JO3587B1 (ar) * | 2010-06-02 | 2020-07-05 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم |
US8383663B2 (en) | 2010-07-19 | 2013-02-26 | Supratek Pharma Inc. | Bendamustine anionic-catioinic cyclopolysaccharide compositions |
TW201306842A (zh) * | 2011-06-15 | 2013-02-16 | Exelixis Inc | 使用pi3k/mtor吡啶並嘧啶酮抑制劑及苯達莫司汀及/或利妥昔單抗治療惡性血液疾病之組合療法 |
PT2744515T (pt) | 2011-08-16 | 2022-05-19 | Morphosys Ag | Terapia de combinação com um anticorpo anti-cd19 e uma mostarda de nitrogénio |
SG2014014419A (en) | 2011-09-13 | 2014-07-30 | Pharmacyclics Inc | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
ES2613838T3 (es) | 2011-09-26 | 2017-05-26 | Fresenius Kabi Oncology Ltd | Un procedimiento mejorado para la preparación de hidrocloruro de bendamustina |
SI2827862T1 (sl) | 2012-03-20 | 2024-03-29 | Eagle Pharmaceuticals, Inc. | Formulacije bendamustina |
CN104271135B (zh) | 2012-03-20 | 2017-05-17 | 赛多斯有限责任公司 | 在要求减少施用容量的患者中治疗苯达莫司汀响应性状况的方法 |
US10220051B2 (en) | 2012-03-29 | 2019-03-05 | Institute For Cancer Research | Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer |
US8927516B2 (en) * | 2012-03-29 | 2015-01-06 | Institute For Cancer Research | Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer |
TWI649081B (zh) | 2013-08-02 | 2019-02-01 | 製藥公司 | 治療固態腫瘤之方法 |
US20150087681A1 (en) * | 2013-09-25 | 2015-03-26 | Pranav Patel | Bendamustine HCL Stable Lyophilized Formulations |
WO2015048718A2 (en) | 2013-09-30 | 2015-04-02 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Inhibition of thymine dna glycosylase in the treatment of cancer |
JP6883428B2 (ja) | 2014-03-13 | 2021-06-09 | ブードーリス,バシリオス | ベンダムスチン固体分散体及び持続注入 |
DK3594343T3 (da) | 2015-07-23 | 2021-06-28 | Inst Curie | Anvendelse af en kombination af dbait-molekyle og parp-inhibitorer til behandling af kræft |
GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
WO2019175132A1 (en) | 2018-03-13 | 2019-09-19 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204335A (en) * | 1986-10-31 | 1993-04-20 | Asta Pharma Aktiengesellschaft | Ifosfamide lyophilisate and process for its preparation |
US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
PL174721B1 (pl) * | 1992-11-13 | 1998-09-30 | Idec Pharma Corp | Przeciwciało monoklonalne anty-CD20 |
US5595721A (en) * | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
PT725642E (pt) * | 1993-10-27 | 2000-05-31 | Upjohn Co | Prostaglandina e 1 estabilizada |
US5955504A (en) * | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
GB9524334D0 (en) * | 1995-11-28 | 1996-01-31 | Philips Electronics Nv | Mos transistor |
US20040072889A1 (en) * | 1997-04-21 | 2004-04-15 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
AU767586B2 (en) * | 1998-07-09 | 2003-11-20 | Cephalon, Inc. | Methods and compositions for the treatment of chronic lymphocytic leukemia |
US5972912A (en) * | 1998-12-17 | 1999-10-26 | S.P. Pharmaceuticals | Method for lyophilizing ifosfamide |
US6569402B1 (en) * | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6380210B1 (en) * | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
US6545034B1 (en) * | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
CA2431319A1 (en) * | 2000-12-11 | 2002-06-20 | Hiroto Bando | Pharmaceutical composition having an improved water solubility |
US20040053972A1 (en) * | 2000-12-11 | 2004-03-18 | Eiji Nara | Medicinal compositions having improved absorbability |
BR0213279A (pt) * | 2001-10-15 | 2004-10-26 | Hemoteq Gmbh | Revestimento de stents para impedir a restenose |
US6613927B1 (en) * | 2002-02-08 | 2003-09-02 | American Pharmaceutical Partners, Inc. | Sterile lyophilized ifosfamide and associated methods |
EP1501565B1 (de) * | 2002-05-09 | 2006-11-02 | Hemoteq GmbH | Verbindungen und verfahren zur hemokompatiblen beschichtung von oberflächen |
US20040096436A1 (en) * | 2002-08-02 | 2004-05-20 | Regents Of The University Of California | Methods for inhibiting protein kinases in cancer cells |
US6966329B2 (en) * | 2003-01-27 | 2005-11-22 | Hydraforce, Inc. | Proportional pilot-operated flow control valve |
DE10304403A1 (de) * | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
TW200427463A (en) * | 2003-02-14 | 2004-12-16 | Salmedix | Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
-
2005
- 2005-11-04 CN CN201010001516XA patent/CN101933923A/zh active Pending
- 2005-11-04 US US11/267,010 patent/US20060128777A1/en not_active Abandoned
- 2005-11-04 TW TW094138843A patent/TW200621240A/zh unknown
- 2005-11-04 MX MX2007005361A patent/MX2007005361A/es not_active Application Discontinuation
- 2005-11-04 JP JP2007540086A patent/JP2008519047A/ja active Pending
- 2005-11-04 WO PCT/US2005/040068 patent/WO2006065392A2/en active Application Filing
- 2005-11-04 AR ARP050104642A patent/AR054094A1/es unknown
- 2005-11-04 AU AU2005317047A patent/AU2005317047A1/en not_active Abandoned
- 2005-11-04 CA CA002585659A patent/CA2585659A1/en not_active Abandoned
- 2005-11-04 EP EP05851374A patent/EP1814544A4/en not_active Withdrawn
-
2007
- 2007-05-24 NO NO20072654A patent/NO20072654L/no not_active Application Discontinuation
-
2009
- 2009-02-18 US US12/372,910 patent/US20090209606A1/en not_active Abandoned
- 2009-08-12 CL CL2009001721A patent/CL2009001721A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006065392A3 (en) | 2006-12-21 |
AU2005317047A1 (en) | 2006-06-22 |
NO20072654L (no) | 2007-07-25 |
JP2008519047A (ja) | 2008-06-05 |
US20090209606A1 (en) | 2009-08-20 |
CN101933923A (zh) | 2011-01-05 |
CA2585659A1 (en) | 2006-06-22 |
EP1814544A4 (en) | 2009-12-02 |
MX2007005361A (es) | 2008-01-11 |
AR054094A1 (es) | 2007-06-06 |
TW200621240A (en) | 2006-07-01 |
WO2006065392A8 (en) | 2007-03-01 |
EP1814544A2 (en) | 2007-08-08 |
US20060128777A1 (en) | 2006-06-15 |
WO2006065392A2 (en) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001721A1 (es) | Uso de bendamustina para preparar un medicamento util para tratar el cancer. | |
CL2015002978A1 (es) | Uso de 2,3-dihidroimidazo[1,2-c]quinazolinas sustituidas | |
ECSP088932A (es) | Nuevos compuestos químicos | |
CL2012002844A1 (es) | Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende; y su uso en el tratamiento de un trastorno proliferativo de celulas tal como cancer (divisional solicitud nº 311-07). | |
TW200619184A (en) | New compound and organic light-emitting device using the same (7) | |
CL2010000320A1 (es) | Un compuesto 8-(1,3-dihidro-isoindol-2-ilmetil)-2,9-dihidro-1,2,7,9-tetraaza-fenalen-3-ona, como inhibidor de parp; composicion farmaceutica; y su uso para el tratamiento del cancer. | |
AR091405A2 (es) | Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen | |
CR11366A (es) | Compuestos quimicos | |
CL2009000742A1 (es) | Forma solida cristalina de clorhidrato de bendamustina, designada como forma 1; composicion farmaceutica que la comprende; metodo de preparacion de la composicion farmaceutica; y uso en el tratamiento de leucemia linfocitica cronica, enfermedad de hodgkin, linfoma no hodgkiniano, mieloma multiple o cancer de mama. | |
HN2003000094A (es) | Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. | |
ECSP066882A (es) | Compuestos de imidazol | |
CR20110001A (es) | Compuesto heterocíclico y uso del mismo | |
UY28731A1 (es) | Compuestos quimicos | |
PH12013500772A1 (en) | Transdermal therapeutic system | |
CL2007001670A1 (es) | Uso de compuestos derivados de amina para el tratamiento de un trastorno mediado por citoquinas. | |
ECSP077130A (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos | |
ATE512206T1 (de) | Organische elektrolumineszenzvorrichtung | |
ATE359340T1 (de) | Verwendung von platin(ii)-komplexen als lumineszierende materialien in organischen licht- emittierenden dioden (oleds) | |
CL2008001213A1 (es) | Uso de compuestos derivados de piridin-4-il-benceno-1,4-diamino sustituidos por alquindol para preparar un medicamento para el tratamiento de un trastorno proliferativo tal como el cancer. | |
ATE450489T1 (de) | Verbindungen auf basis von fluoranthen und ihre verwendung | |
DOP2004001024A (es) | Compuestos de pirazolilo e imidazolilo biciclicos y usos de los mismos | |
BR112012033027A2 (pt) | elemento de corte de ferramentas de sondagem, ferramentas de sondagem incluindo tais elementos de corte, e métodos de formação de elementos de corte para ferramentas de sondagem | |
ECSP066540A (es) | Pentanoles transpuestos, un método para prepararlos y su uso como antiinflamatorios | |
AR067769A1 (es) | Derivado de ditiazol para el tratamiento del cancer | |
CL2008002826A1 (es) | Compuestos derivados de pirimidina alquiltio sustituidas, antagonista crth2; composicion farmaceutica que comprende a dicho compuestos; y uso para tratar una enfermedad alergica, asma, dermatitis atopica, psoriasis, colitis ulcerantes, sinusitis, leucemia basofilica, entre otras. |